- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2022-003079-41.
Displaying page 1 of 1.
EudraCT Number: 2022-003079-41 | Sponsor Protocol Number: BOLD-100-001 | Start Date*: 2023-01-06 | ||||||||||||||||||||||||||
Sponsor Name:Bold Therapeutics, Inc. (Bold) | ||||||||||||||||||||||||||||
Full Title: A Phase 1b/2a Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid Tumours | ||||||||||||||||||||||||||||
Medical condition: Colorectal Cancer Pancreatic Cancer Gastric Cancers Cholangiocarcinoma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IE (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
